The ParkCycle Study: Aerobic Exercise in PD
The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nijmegen, Netherlands, 6500HB
- UMC St Radboud
-
-
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson's disease according to the UK Queen Square Brain Bank Criteria
- Hoehn & Yahr disease stages I-II
- Age between 30 and 75 years
- Having insufficient physical activity according to the ACSM guideline for adults, 50-64 years old with a chronic condition
- Untreated with anti-parkinsonian medication or receiving medication, for less than two years, medication-responsive without fluctuations.
Exclusion Criteria:
- Unclear diagnosis with Red Flags
- Advanced problems in cognitive functioning: Mini Mental State Examination (MMSE)19 score < 24
- Serious co-morbidity: neurological or orthopedic disorder that severely affects movement; known by specialist or medical practitioner
- Pulmonary diseases; known by specialist or medical practitioner
- Stroke
High risk of cardiovascular complications:
- Hypertension (systole >150 and diastole > 100)
- Diabetes Mellitus; known by specialist or medical practitioner
- Cardiac valve defect (especially aortic valve stenosis); known by specialist or medical practitioner
- Cardiac rhythm disorder; known by specialist or medical practitioner
- Heart failure; known by specialist or medical practitioner
- Use of ß-blockers
- Not able to complete American (for Cleveland site) or Dutch questionnaires (for the Nijmegen site)
- Daily institutionalized care
Contra-indications for fMRI:
- Pregnancy
- Metallic implants or electronic devices
- Previous seizure
- Claustrophobia
- Not able to keep the head still for longer period, i.e. due to severe head tremor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise
Twente patients will perform Aerobic exercise 3 times a week for at least 30 min
|
six-months long exercise intervention on a stationary virtual reality bike, 3-5 times a week, each session lasting 30-45 minutes at a target heart rate (60-85% heart rate reserve).
|
|
No Intervention: Control
Fifteen patients will be listed as a control group and will be instructed to continue their previous level of activity throughout the study
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trails A and B task
Time Frame: every month for 6-7 months
|
this test requires subjects to connect numbers on a screen from 1 to 25 (part A) and to connect numbers to letters.
This neuropsychological test has already been proven to be sensitive to frontal lobe damage (e.g.
Boll 1981) and has been recognised as an outcome for executive function in PD21.
This test is performed using an online system called i-COMET that allows subject to complete the task weekly at home.
Subjects have to login at the i-COMET website (https://i-comet.com)
with a username and password that is provided to them by the research team.
|
every month for 6-7 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
UPDRS
Time Frame: baseline and after 6 months follow-up (FU)
|
baseline and after 6 months follow-up (FU)
|
|
|
Cognitive tests
Time Frame: baseline and after 6 months FU
|
MMSE and SCOPA-org
|
baseline and after 6 months FU
|
|
Kinetics tests
Time Frame: baseline and after 6 months FU
|
Timed Up and Go Test (iTUG) and a postural sway test, , as an objective measure for balance and mobility Finger tap test as a measure for bradykinesia and a pegboard test as a measure for complex motor function
|
baseline and after 6 months FU
|
|
questionaires
Time Frame: baseline and after 6 months FU
|
The PDQ-39 is a PD specific questionnaire including 39 items concerning quality of life.
Other non-motor features such as mood and sleep are respectively measured using the HADS and SCOPA-Sleep.
|
baseline and after 6 months FU
|
|
maximal exercise test
Time Frame: baseline and after 6 months FU
|
to determine training load and subject fitness
|
baseline and after 6 months FU
|
|
feasibility parameters
Time Frame: after 6 months (termination of intervention)
|
Compliance based on the number of completed exercise sessions and the amount of time that patients exercised at their target heart rate.
|
after 6 months (termination of intervention)
|
|
neuroplasticity
Time Frame: baseline and after 6 months FU
|
|
baseline and after 6 months FU
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Bas Bloem, MD PhD, Radboud University Medical Center
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NL38116.091.11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.